Related Articles
SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis
Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma
Combined effects on leukemia cell growth by targeting sphingosine kinase 1 and sirtuin 1 signaling
Upregulation of sphingosine kinase 1 is associated with recurrence and poor prognosis in papillary thyroid carcinoma
Sphingosine kinase‑1 predicts overall survival outcomes in non‑small cell lung cancer patients treated with carboplatin and navelbine